Wittig Olga, Diaz-Solano Dylana, Cardier José
Unidad de Terapia Celular-Laboratorio de Patología Celular y Molecular, Centro de Medicina Experimental, Instituto Venezolano de Investigaciones Científicas (IVIC), Apartado 21827, Caracas 1020-A, Venezuela.
Unidad de Terapia Celular-Laboratorio de Patología Celular y Molecular, Centro de Medicina Experimental, Instituto Venezolano de Investigaciones Científicas (IVIC), Apartado 21827, Caracas 1020-A, Venezuela.
Injury. 2018 Jun;49(6):1052-1057. doi: 10.1016/j.injury.2018.04.005. Epub 2018 Apr 5.
There is evidence showing that human mesenchymal stromal cells (MSC) seeded on collagen microspheres (CM) and incorporated into platelet rich plasma (PRP) clots induce bone formation. For clinical trials it is very important to establish standardization of storage and shipment conditions to ensure the viability and functionality of cellular products. We investigate the effect of storage temperature and time on the viability and functionality of human MSC seeded on CM and included into PRP clots for using in the further clinical application for bone regeneration.
MSC/CM/PRP clots were stored at room temperature (RT), 4 °C and 37 °C for 12 h, 24 h and 48 h. At each period of time, MSC were evaluated for their viability and functionality.
MSC from MSC/CM/PRP clots maintained at RT and 37 °C for 24 h showed a high viability (90%) and maintained their capacity of proliferation, migration and osteogenic differentiation. In contrast, MSC/CM/PRP maintained to 4 °C showed a significant reduction in their viability and migration capacity. MSC from MSC/CM/PRP clots maintained at RT for 24 h induce osteogenesis in the subcutaneous tissues of mice, after four months of transplantation.
Our results show that MSC incorporated into CM/PRP clots and maintained at RT can be utilized in bone regeneration protocols during the first 24 h after their processing.
有证据表明,接种于胶原微球(CM)并整合到富血小板血浆(PRP)凝块中的人间充质基质细胞(MSC)可诱导骨形成。对于临床试验而言,建立储存和运输条件的标准化以确保细胞产品的活力和功能非常重要。我们研究储存温度和时间对接种于CM并包含在PRP凝块中的人MSC的活力和功能的影响,以便用于进一步的骨再生临床应用。
将MSC/CM/PRP凝块分别在室温(RT)、4℃和37℃下储存12小时、24小时和48小时。在每个时间段,评估MSC的活力和功能。
在RT和37℃下保存24小时的MSC/CM/PRP凝块中的MSC显示出高活力(90%),并保持其增殖、迁移和成骨分化能力。相比之下,保存在4℃的MSC/CM/PRP的活力和迁移能力显著降低。移植四个月后,在RT下保存24小时的MSC/CM/PRP凝块中的MSC可在小鼠皮下组织中诱导成骨。
我们的结果表明,整合到CM/PRP凝块中并在RT下保存的MSC在其处理后的前24小时可用于骨再生方案。